Fate Therapeutics FATE
NASDAQ FATE
$2.37 -0.01 (-0.42%)
At close: Sep 30, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Interest Expenses (2013 - 2019)

Updated

Fate Therapeutics (FATE) recorded Interest Expenses of $586,000 in Q4 2019, up 35.0% from $434,000 a year earlier and up 46.5% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Interest Expenses (2013 - 2019) Analysis & Trends

For FY2019, Fate Therapeutics reported Interest Expenses of $1.8 million, up 5.9% from FY2018.

  • Annual Interest Expenses has a five-year compound annual growth rate of 26.8% (FY2014 to FY2019).
  • Across earlier years, Interest Expenses came in at $1.7 million in FY2018 (+34.1%), $1.27 million in FY2017 (-22.5%), $1.64 million in FY2016 (-26.3%) and $2.22 million in FY2015 (+304.4%).
  • The Q4 2019 figure is the highest quarterly Interest Expenses since Q3 2015.
  • On a year-over-year basis, Interest Expenses rose in five of the last eight quarters, with growth averaging 24.6%.
  • Peak year-over-year performance for Interest Expenses in the last five years was growth of 220.9% in Q3 2015, against a decline of 51.3% in Q2 2017 at the low end.
  • Per Business Quant, the preceding three quarters came in at $400,000 (Q3 2019), $409,000 (Q2 2019) and $405,000 (Q1 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Fate Therapeutics 276.57 Mn 276.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 586,000.00
Sep 30, 2019 400,000.00
Jun 30, 2019 409,000.00
Mar 31, 2019 405,000.00
Dec 31, 2018 434,000.00
Sep 30, 2018 429,000.00
Jun 30, 2018 425,000.00
Mar 31, 2018 412,000.00
Dec 31, 2017 412,000.00
Sep 30, 2017 378,000.00
Jun 30, 2017 212,000.00
Mar 31, 2017 266,000.00
Dec 31, 2016 329,000.00
Sep 30, 2016 385,000.00
Jun 30, 2016 435,000.00
Mar 31, 2016 500,000.00
Dec 31, 2015 520,000.00
Sep 30, 2015 600,000.00
Jun 30, 2015 600,000.00
Mar 31, 2015 600,000.00
API Access

Fate Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=FATE&period=max&api_key=YOUR_API_KEY